Prenatal transplantation of cytokine-stimulated marrow improves early chimerism in a resistant strain combination but results in poor long-term engraftment

Experimental Hematology

Volumn 34, Issue 9, 2006, Pages 1277-1286

  Shaaban, Aimen F ^a   Kim, Heung Bae ^b   Gaur, Lasya ^a   Liechty, Kenneth W ^c   Flake, Alan W ^c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; STEM CELL FACTOR; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CULTURE; CELL STIMULATION; CHIMERA; COLONY FORMING UNIT; CONTROLLED STUDY; DONOR; FEMALE; FETUS; GRAFT RECIPIENT; GRAFT SURVIVAL; IMMUNITY; IN UTERO STEM CELL TRANSPLANTATION; MALE; MICROCHIMERISM; MOUSE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RELIABILITY; SKIN ALLOGRAFT; SUPPLEMENTATION; TIME; TRANSPLANTATION TOLERANCE; ANIMAL; BAGG ALBINO MOUSE; BONE MARROW CELL; CELL CULTURE; COMBINED IMMUNODEFICIENCY; DRUG EFFECT; FETUS DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METHODOLOGY; PREGNANCY; SKIN TRANSPLANTATION;

ANIMALIA; MURINAE; PRIMATES;

ANIMALS; BONE MARROW CELLS; CELLS, CULTURED; FEMALE; FETAL DISEASES; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNE TOLERANCE; MICE; MICE, INBRED BALB C; PREGNANCY; SEVERE COMBINED IMMUNODEFICIENCY; SKIN TRANSPLANTATION; STEM CELL FACTOR; TIME FACTORS; TRANSPLANTATION CHIMERA; TRANSPLANTATION IMMUNOLOGY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33748654220     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2006.05.007     Document Type: Article

References (67)

1. Shaaban A.F., and Flake A.W. Fetal hematopoietic stem cell transplantation. Semin Perinatol 23 (1999) 515-523
2. Flake A.W. In utero stem cell transplantation. Best Pract Res Clin Obstet Gynaecol 18 (2004) 941-958
3. Flake A.W. In utero transplantation of haemopoietic stem cells. Best Pract Res Clin Haematol 14 (2001) 671-683
4. Flake A.W., and Zanjani E.D. In utero hematopoietic stem cell transplantation. A status report. JAMA 278 (1997) 932-937
5. Flake A.W., Roncarolo M.G., Puck J.M., et al. Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med 335 (1996) 1806-1810
6. Hayashi S., and Flake A.W. In utero hematopoietic stem cell therapy. Yonsei Med J 42 (2001) 615-629
7. Westgren M., Ringden O., Bartmann P., et al. Prenatal T-cell reconstitution after in utero transplantation with fetal liver cells in a patient with X-linked severe combined immunodeficiency. Am J Obstet Gynecol 187 (2002) 475-482
8. Wengler G.S., Lanfranchi A., Frusca T., et al. In-utero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDXI). Lancet 348 (1996) 1484-1487
9. Shields L.E., Gaur L., Delio P., Potter J., Sieverkropp A., and Andrews R.G. Fetal immune suppression as adjunctive therapy for in utero hematopoietic stem cell transplantation in nonhuman primates. Stem Cells 22 (2004) 759-769
10. Shields L.E., Gaur L.K., Gough M., Potter J., Sieverkropp A., and Andrews R.G. In utero hematopoietic stem cell transplantation in nonhuman primates: the role of T cells. Stem Cells 21 (2003) 304-314
11. Crombleholme T.M., Langer J.C., Harrison M.R., and Zanjani E.D. Transplantation of fetal cells. Am J Obstet Gynecol 164 (1991) 218-230
12. Andreoletti M., LePercq J., Loux N., et al. In utero allotransplantation of retrovirally transduced fetal hepatocytes in primates: feasibility and short-term follow-up. J Matern Fetal Med 7 (1998) 296-303
13. Muench M.O., and Barcena A. Stem cell transplantation in the fetus. Cancer Control 11 (2004) 105-118
14. Lee P.W., Cina R.A., Randolph M.A., et al. In utero bone marrow transplantation induces kidney allograft tolerance across a full major histocompatibility complex barrier in Swine. Transplantation 79 (2005) 1084-1090
15. Lee P.W., Cina R.A., Randolph M.A., et al. Stable multilineage chimerism across full MHC barriers without graft-versus-host disease following in utero bone marrow transplantation in pigs. Exp Hematol 33 (2005) 371-379
16. Hayashi S., Peranteau W.H., Shaaban A.F., and Flake A.W. Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion. Blood 100 (2002) 804-812
17. Peranteau W.H., Hayashi S., Hsieh M., Shaaban A.F., and Flake A.W. High-level allogeneic chimerism achieved by prenatal tolerance induction and postnatal nonmyeloablative bone marrow transplantation. Blood 100 (2002) 2225-2234
18. Hayashi S, Hsieh M, Peranteau WH, Ashizuka S, Flake AW. Complete allogeneic hematopoietic chimerism achieved by in utero hematopoietic cell transplantation and cotransplantation of LLME-treated, MHC-sensitized donor lymphocytes. Exp Hematol. 32:290-299.
19. Hayashi S., Abdulmalik O., Peranteau W.H., et al. Mixed chimerism following in utero hematopoietic stem cell transplantation in murine models of hemoglobinopathy. Exp Hematol 31 (2003) 176-184
20. Holyoake T.L., Freshney M.G., McNair L., et al. Ex vivo expansion with stem cell factor and interleukin-11 augments both short-term recovery posttransplant and the ability to serially transplant marrow. Blood 87 (1996) 4589-4595
21. Ziegler B.L., Valtieri M., Porada G.A., et al. KDR receptor: a key marker defining hematopoietic stem cells. Science 285 (1999) 1553-1558
22. Umeda K., Heike T., Yoshimoto M., et al. Development of primitive and definitive hematopoiesis from nonhuman primate embryonic stem cells in vitro. Development 131 (2004) 1869-1879
23. Perlingeiro R.C., Kyba M., Bodie S., and Daley G.Q. A role for thrombopoietin in hemangioblast development. Stem Cells 21 (2003) 272-280
24. Nakayama N., Lee J., and Chiu L. Vascular endothelial growth factor synergistically enhances bone morphogenetic protein-4-dependent lymphohematopoietic cell generation from embryonic stem cells in vitro. Blood 95 (2000) 2275-2283
25. Miyagi T., Takeno M., Nagafuchi H., Takahashi M., and Suzuki N. Flk1+ cells derived from mouse embryonic stem cells reconstitute hematopoiesis in vivo in SCID mice. Exp Hematol 30 (2002) 1444-1453
26. Hidaka M., Stanford W.L., and Bernstein A. Conditional requirement for the Flk-1 receptor in the in vitro generation of early hematopoietic cells. Proc Natl Acad Sci U S A 96 (1999) 7370-7375
27. Ema M., Faloon P., Zhang W.J., et al. Combinatorial effects of Flk1 and Tal1 on vascular and hematopoietic development in the mouse. Genes Dev 17 (2003) 380-393
28. Cortes F., Debacker C., Peault B., and Labastie M.C. Differential expression of KDR/VEGFR-2 and CD34 during mesoderm development of the early human embryo. Mech Dev 83 (1999) 161-164
29. Briddell R.A., Hartley C.A., Smith K.A., and McNiece I.K. Recombinant rat stem cell factor synergizes with recombinant human granulocyte colony-stimulating factor in vivo in mice to mobilize peripheral blood progenitor cells that have enhanced repopulating potential. Blood 82 (1993) 1720-1723
30. Yednock T.A., Cannon C., Vandevert C., et al. Alpha 4 beta 1 integrin-dependent cell adhesion is regulated by a low affinity receptor pool that is conformationally responsive to ligand. J Biol Chem 270 (1995) 28740-28750
31. Kovach N.L., Lin N., Yednock T., Harlan J.M., and Broudy V.C. Stem cell factor modulates avidity of alpha 4 beta 1 and alpha 5 beta 1 integrins expressed on hematopoietic cell lines. Blood 85 (1995) 159-167
32. Legras S., Levesque J.P., Charrad R., et al. CD44-mediated adhesiveness of human hematopoietic progenitors to hyaluronan is modulated by cytokines. Blood 89 (1997) 1905-1914
33. Peled A., Petit I., Kollet O., et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283 (1999) 845-848
34. Hart C., Drewel D., Mueller G., et al. Expression and function of homing-essential molecules and enhanced in vivo homing ability of human peripheral blood-derived hematopoietic progenitor cells after stimulation with stem cell factor. Stem Cells 22 (2004) 580-589
35. Peters S.O., Kittler E.L., Ramshaw H.S., and Quesenberry P.J. Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 87 (1996) 30-37
36. Kim H.B., Shaaban A.F., Yang E.Y., Liechty K.W., and Flake A.W. Microchimerism and tolerance after in utero bone marrow transplantation in mice. J Surg Res 77 (1998) 1-5
37. Kim H.B., Shaaban A.F., Milner R., Fichter C., and Flake A.W. In utero bone marrow transplantation induces donor-specific tolerance by a combination of clonal deletion and clonal anergy. J Pediatr Surgery 34 (1998) 726-729 discussion 729-730
38. Tavassoli M. Embryonic and fetal hemopoiesis: an overview. Blood Cells 17 (1991) 269-281 discussion 282-286
39. Cashman J., Clark-Lewis I., Eaves A., and Eaves C. Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD/SCID mice. Blood 99 (2002) 792-799
40. Craddock C., Nakamoto B., Elices M., and Papayannopoulou T. The role of CS1 moiety of fibronectin in VLA mediated haemopoietic progenitor trafficking. Br J Haematol 97 (1997) 15-21
41. Deguchi T., and Komada Y. Homing-associated cell adhesion molecule (H-CAM/CD44) on human CD34+ hematopoietic progenitor cells. Leuk Lymphoma 40 (2000) 25-37
42. Hendrikx P.J., Martens C.M., Hagenbeek A., Keij J.F., and Visser J.W. Homing of fluorescently labeled murine hematopoietic stem cells. Exp Hematol 24 (1996) 129-140
43. Hidalgo A., Sanz-Rodriguez F., Rodriguez-Fernandez J.L., et al. Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-dependent adhesion to fibronectin and VCAM-1 on bone marrow hematopoietic progenitor cells. Exp Hematol 29 (2001) 345-355
44. Hinds K.A., Hill J.M., Shapiro E.M., et al. Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood 102 (2003) 867-872
45. Matsuzaki Y., Kinjo K., Mulligan R.C., and Okano H. Unexpectedly efficient homing capacity of purified murine hematopoietic stem cells. Immunity 20 (2004) 87-93
46. Papayannopoulou T., and Craddock C. Homing and trafficking of hemopoietic progenitor cells. Acta Haematol 97 (1997) 97-104
47. Shaaban A.F., Kim H.B., Milner R., and Flake A.W. A kinetic model for the homing and migration of prenatally transplanted marrow. Blood 94 (1999) 3251-3257
48. Tavassoli M., and Minguell J.J. Homing of hemopoietic progenitor cells to the marrow. Proc Soc Exp Biol Med 196 (1991) 367-373
49. Zanjani E.D., Flake A.W., Almeida-Porada G., Tran N., and Papayannopoulou T. Homing of human cells in the fetal sheep model: modulation by antibodies activating or inhibiting very late activation antigen-4-dependent function. Blood 94 (1999) 2515-2522
50. Shaaban A.F., Kim H.B., Liechty K.W., Milner R., and Flake A.W. Blockade of a4 or b1 integrins impairs homing of prenatally transplanted allogeneic marrow to the fetal liver. Blood 90 suppl 1, abstr 2168 (1997) 488a
51. Tavassoli M., and Hardy C.L. Molecular basis of homing of intravenously transplanted stem cells to the marrow. Blood 76 (1990) 1059-1070
52. Papayannopoulou T., Craddock C., Nakamoto B., Priestley G.V., and Wolf N.S. The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proc Natl Acad Sci U S A 92 (1995) 9647-9651
53. Oostendorp R.A., and Dormer P. VLA-4-mediated interactions between normal human hematopoietic progenitors and stromal cells. Leuk Lymphoma 24 (1997) 423-535
54. Levesque J.P., Haylock D.N., and Simmons P.J. Cytokine regulation of proliferation and cell adhesion are correlated events in human CD34+ hemopoietic progenitors. Blood 88 (1996) 1168-1176
55. Ferber I., Schönrich G., Schenkel J., Mellor A.L., Hämmerling G.J., and Arnold B. Levels of peripheral T cell tolerance induced by different doses of tolerogen. Science 263 (1994) 674-676
56. Hammerling G.J., Schonrich G., Ferber I., and Arnold B. Peripheral tolerance as a multi-step mechanism. Immunological Rev 133 (1993) 93-104
57. Ramsdell F., and Fowlkes B.J. Maintenance of in vivo tolerance by persistence of antigen. Science 257 (1992) 1130-1134
58. Kaufman C.L., Colson Y.L., Wren S.M., Watkins S., Simmons R.L., and Ildstad S.T. Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 84 (1994) 2436-2446
59. Gaines B.A., Colson Y.L., Kaufman C.L., and Ildstad S. Facilitating cells enable engraftment of purified fetal liver stem cells in allogeneic recipients. Exp Hematol 24 (1996) 902-913
60. Li C.L., and Johnson G.R. Stem cell factor enhances the survival but not the self-renewal of murine hematopoietic long-term repopulating cells. Blood 84 (1994) 408-414
61. Trevisan M., Yan X.Q., and Iscove N.N. Cycle initiation and colony formation in culture by murine marrow cells with long-term reconstituting potential in vivo. Blood 88 (1996) 4149-4158
62. Traycoff C.M., Cornetta K., Yoder M.C., Davidson A., and Srour E.F. Ex vivo expansion of murine hematopoietic progenitor cells generates classes of expanded cells possessing different levels of bone marrow repopulating potential. Exp Hematol 24 (1996) 299-306
63. Peters S.O., Kittler E.L., Ramshaw H.S., and Quesenberry P.J. Murine marrow cells expanded in culture with IL-3, IL-6, IL-11, and SCF acquire an engraftment defect in normal hosts. Exp Hematol 23 (1995) 461-469
64. Sefrioui H., Donahue J., Srivastava A.S., Gilpin E., Lee T.H., and Carrier E. Alloreactivity following in utero transplantation of cytokine-stimulated hematopoietic stem cells: the role of recipient CD4(-) cells. Exp Hematol 30 (2002) 617-624
65. Sugiura K., Yasumizu R., Iwai H., et al. Long-term immunologic tolerance induction in chimeric mice after bone marrow transplantation across major histocompatibility barriers: persistent or redeveloping immunologic responsiveness after prolonged survival. Thymus 18 (1991) 137-153
66. Hashimoto F., Sugiura K., Inoue K., and Ikehara S. Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vivo. Blood 89 (1997) 49-54
67. Hisha H., Nishino T., Kawamura M., Adachi S., and Ikehara S. Successful bone marrow transplantation by bone grafts in chimeric-resistant combination. Exp Hematol 23 (1995) 347-352